22° Sunny

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

3.135 +0.025 (+0.80%)

Streaming Delayed Price Updated: 9:45 AM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026

February 09, 2026

From Maravai LifeSciences, Inc.

Via Business Wire

Teleflex Stock Slides 39% in a Year, but This $8.5 Million Buy Signals a Contrarian Bet ↗

February 06, 2026

This medical device firm supplies hospitals worldwide with single-use products for critical care, surgery, and interventional procedures.

Via The Motley Fool

Topics Regulatory Compliance

What to Know About a New $9 Million Bet on an Energy Distributor Stock ↗

February 06, 2026

This energy sector distributor delivers maintenance, repair, and supply chain solutions to industrial clients across a global network.

Via The Motley Fool

Topics Economy Regulatory Compliance

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

What to Expect from Maravai LifeSciences's Earnings ↗

August 08, 2025

Via Benzinga

This Biopharma Stock Has Surged Nearly 100% and One Fund Just Locked in Gains With a $10 Million Exit ↗

February 06, 2026

Arcutis Biotherapeutics develops topical therapies for chronic skin conditions, with a portfolio targeting psoriasis and atopic dermatitis.

Via The Motley Fool

Maravai LifeSciences Announces November 2025 Investor Conference Schedule

November 10, 2025

From Maravai LifeSciences, Inc.

Via Business Wire

Maravai LifeSciences (MRVI) Stock Plummets After Q3 2025 Revenue Miss and Weak Guidance ↗

November 06, 2025

Maravai LifeSciences (MRVI) stock fell after Q3 2025 revenue missed estimates. The company reported a net loss and provided full-year guidance below analyst expectations.

Via Chartmill

Maravai LifeSciences Reports Third Quarter 2025 Financial Results

November 06, 2025

From Maravai LifeSciences Holdings, Inc.

Via Business Wire

MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders

October 29, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025

October 22, 2025

From Maravai LifeSciences, Inc.

Via Business Wire

MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 02, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

September 09, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

August 11, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports

August 11, 2025

Today, August 11, 2025, marks a significant day for investors looking beyond the typical S&P 500 giants, as a diverse array of companies across various sectors unveiled their latest quarterly earnings....

Via MarketMinute

Topics Economy Stocks

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

July 28, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI

July 25, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

July 22, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

July 14, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

July 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI

June 27, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

June 25, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

June 24, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors

June 09, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology

June 03, 2025

From TriLink BioTechnologies

Via Business Wire

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

May 21, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai LifeSciencesReleases 2024 Sustainability Report

May 21, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

May 20, 2025

From TriLink BioTechnologies

Via Business Wire

TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines

May 14, 2025

From TriLink BioTechnologies

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

Sections

Services